DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	KRT33A; KRT34; KRT37; KRT38; KRT75; KRT14; KRT6B; KRT18; KRT8; IVL; KRT19; KRT7; SPRR2D; CASP14; SPRR2B; KRT17; DSG2; SPINK9; LCE1A; LIPN; LIPM; KRT40; SPINK6; KRT27; KRT35; SPRR2F; LCE3D; SPRR2G; KLK14; KLK5;	GO:0070268~cornification	30	113	26.5486725663717	0.00019684736645475	0.236069204220865	0.943686274784098	0.944276816883462	0.884632064847671	0.943686274784098	1
down	HOXC11; TBX1; GLI2; HOXB8; NR2F2; HOXD10; MSX1; HOXD3; HOXA11; HOXC8; HOXC13; HOXD13; LHX1; HHEX; EMX2; CYP26C1; ALX4; HOXC10; HOXC6; HOXC5; HES4; HOXA6; HOXD9; HOXC9; HOXD4; HES2; HES7;	GO:0009952~anterior/posterior pattern specification	27	99	27.2727272727273	0.00027928956353173	0.267950407252349	1	1	0.996225873117706	0.999999873474933	1
down	EDN1; TFPI; CD40; PCK1; SOX9; CD47; PTGIS; ZC3H12A; NLRP7; HAS2; ADAMTS7; PYCARD; CCL16; CCL8; CCL14; CCL21; XCL1; CCL26; CCL20; CX3CL1; CCL24; CCL18; CCL19;	GO:0071347~cellular response to interleukin-1	23	81	28.3950617283951	0.0004766860454336	0.381110493324167	1	1	0.999999873474933	0.999999873474933	1
down	CXCR1; CCR2; XCR1; CX3CL1; GPR17; ACKR1; GPR35; CCL26; CCL16; CCL21; CCL24; CXCL3; CCL14; TFF2; CXCL13; CCL20; CCL8; XCL1; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	20	70	28.5714285714286	0.00101336713993649	0.694446024325052	1	1	0.999999873474933	0.999999873474933	1
down	HOXD10; ISL1; ISL2; HOXC10; LHX3; MNX1;	GO:0021520~spinal cord motor neuron cell fate specification	6	7	85.7142857142857	0.0012450577664731	0.746567763221433	1	1	0.999999873474933	0.999999873474933	1
down	EVPLL; LCE2B; KRT34; HLA-DRB1; KRT14; PTHLH; FGF7; SPRR2D; S100A7; CASP14; NTF4; SPRR2B; FABP5; BNC1; LAMB3; LAMC2; LAMA3; ACER1; SPRR2F; SPRR2G; KLK5;	GO:0008544~epidermis development	21	82	25.609756097561	0.00241156998398162	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	APOA1; APOE; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	6	9	66.6666666666667	0.00301257896286333	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	BMP5; GJC1; CSRP3; TBX2; SGCG; GATA4; SGCD; GATA5;	GO:0048738~cardiac muscle tissue development	8	18	44.4444444444444	0.00424782909219623	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FGF10; HOXC11; FGF1; HOXA11; GDNF; SIX1;	GO:0001759~organ induction	6	10	60	0.00439180583236642	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CHL1; TERT; TOX3; EN2; MDK; AXL; GABRA5; GDNF; GCLM; NES; DLX1; ISL1; EN1; GRIK2; NAIP; NFATC4; ANGPT1; SIX1; BHLHB9; SLC30A10; TFAP2B; VSTM2L; PARK7; FAIM2; FOXQ1; SIX4; APOE; NTF4; NTF3;	GO:0043524~negative regulation of neuron apoptotic process	29	138	21.0144927536232	0.00524760043601791	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CYP26A1; UGT1A1; UGT1A3; ALDH1A3; CYP27C1; UGT1A7; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	9	25	36	0.00743000348456901	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	SNAI2; GREM1; APOE; MDK; IGFBP4; IGFBP6; PSMA1; PSMA2; PSMA4; PSMB8; PSMB9; PSMA5; SOX2; SOX9; PSMB3; ISL1; ROR2; CAV1; TLE2; PSME1; RBMS3; SHISA6; HECW1; KREMEN2; PTPRU; NKD2; DACT3; SOST; FERMT1; DKK3; DKK2; MAD2L2; PSME2; NOTUM;	GO:0090090~negative regulation of canonical Wnt signaling pathway	34	179	18.9944134078212	0.0100445614276681	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	APOA1; APOE; APOC3; APOA4; CETP; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	7	17	41.1764705882353	0.0101126830984899	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CCL21; CD5L; LY86; TNF; IL5; FOLR2; ALOX15; DPEP1; SELE; ITGB6; IGFBP4; CRHBP; CD40; CD40LG; AXL; FCGR2B; CNR2; HRH1; XCR1; CSRP3; NLRP6; CD47; FUT7; NAIP; NFATC4; PRKD1; GPR68; CDO1; ZC3H12A; NLRP10; PLD3; SCUBE1; TNIP2; PLD4; PARK7; CCL19; RARRES2; CYP4F11; PLGRKT; NOX4; PYCARD; PTGDR; ACKR1; CCL8; CXCL13; CCL16; CCL24; CCL14; RELB; GPR33; CCL26; TNFRSF4; IL1A; IL36RN; XCL1; CCL18; IL1F10; FPR3; CX3CL1; CCR2; IL2RA; CCL20; CXCL3;	GO:0006954~inflammatory response	63	381	16.5354330708661	0.0102888413061696	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	APOA1; APOE; APOC3; LPL; CETP; NR1H3; GPIHBP1; ANGPTL4; APOA4;	GO:0070328~triglyceride homeostasis	9	27	33.3333333333333	0.010993390526947	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	SRRM4; VAMP5; TFF1; INHA; FGF1; MGP; ROS1; TYMP; MDK; HIST1H1T; COL15A1; ADCYAP1R1; CAV3; FOXL2; TPPP2; BNC1; HHEX; MECOM; COL19A1; ANGPT1; SHB; PKDCC; ZC3H12A; ACSBG2; NKAPL; NXN; MYO7B; PLET1; ATRAID; ATOH7; OSR1; ACER1; PTPRU; ZIC5; MMP19; RARRES2; BCL7B; CHRDL1; RBM24; TEX15; RAI14; THEG; DLX1; DLX2; FST; NKX2-8; HES7; NR2F2; FOXA2; FOXA1; FOXD4L3; SPINK6; EYA4; SOX1; NR1I2; CAV1; ID1; ZFPM2; FOXI3; NKX6-1; FOXL1; FOXD4; RXRG; SOX4; ONECUT3; CCDC160; FOXC2; NR2E1; NKX6-2; FOXQ1; HNF4G; FOXD3; EYA2; SRY; NR1H3; ELF5; FOXD1; FSTL1; SOX2; SPIB; SLA; HES2; NKX1-2; HES4; ID4; FOXD4L4; PPARG; CAV2; FOXE1;	GO:0030154~cell differentiation	89	572	15.5594405594406	0.0110893015768926	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FGF10; MDK; FGF7; CDH3; HAS2; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	6	13	46.1538461538462	0.011271752732703	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	APOE; APOA4; LPL; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	5	9	55.5555555555556	0.0117021697778222	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FCGR2B; NR1H3; ZC3H12A; ADGRF5; IL31RA;	GO:0043031~negative regulation of macrophage activation	5	9	55.5555555555556	0.0117021697778222	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ALDH1A3; MFAP2; FOXL2; EFEMP1; VAX2;	GO:0048048~embryonic eye morphogenesis	5	9	55.5555555555556	0.0117021697778222	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ID1; YWHAH; NFATC4; TRPC5; TRPC6;	GO:0050774~negative regulation of dendrite morphogenesis	5	9	55.5555555555556	0.0117021697778222	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	KCNA5; GJC1; KCNQ1; ANK2; SCN5A;	GO:0086014~atrial cardiac muscle cell action potential	5	9	55.5555555555556	0.0117021697778222	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TREH; DCN; ELN; COL9A1; PAX3; PAX6; LHX1; VEGFC; EFNB2; NKX6-1; TLE2; PHLDA2; LHX3; LAMB1; LAMC2; LAMA1; NTN1; ATRNL1; NTN3; LAMB3; EGFLAM; LAMA3; LAMC3;	GO:0009887~animal organ morphogenesis	23	111	20.7207207207207	0.0136181347363664	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TNFRSF11B; ADAMTS4; INHA; GLI2; PTHLH; FST; BMP5; HOXA11; HOXA13; HOXD12; HOXD13; SOX9; PRELP; CDH11; EN1; SOX4; COL19A1; TEAD4; PKDCC; EXTL1; HES7; ALX4; TP63; HOXC10; HOXD4; MMP16; HAPLN1;	GO:0001501~skeletal system development	27	137	19.7080291970803	0.0137195254332745	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7;	GO:0052695~cellular glucuronidation	6	14	42.8571428571429	0.0146861732105097	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	LCE6A; LCE2B; KRT33A; KRT34; KRT37; KRT38; KRT75; KRT14; KRT6B; KRT18; KRT8; KRT19; KRT7; KRTAP2-3; CDH3; CASP14; KRT17; DSG2; LCE3C; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE2A; LCE2C; LCE2D; KRT40; KRTAP5-7; KRT27; KRT35; KRTAP4-1;	GO:0031424~keratinization	33	181	18.232044198895	0.0178816183981227	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0185364907530273	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	SAT2; SAT1; SATL1;	GO:0032918~spermidine acetylation	3	3	100	0.0185364907530273	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CCL21; NCKAP1L; CIB1; FOXC2; FERMT1; P2RY12;	GO:0033630~positive regulation of cell adhesion mediated by integrin	6	15	40	0.018757038620376	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ADH1A; CYP2A6; CYP2C9; UGT1A1; CYP2C19; AOX1; VKORC1; UGT1A7;	GO:0017144~drug metabolic process	8	25	32	0.0193585170970026	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	NR1I2; CYP2A6; CYP2C9; CYP2C19; CYP2W1; CYP2F1; CYP2A7; CYP2G1P;	GO:0042738~exogenous drug catabolic process	8	25	32	0.0193585170970026	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	SNAI2; GREM1; GLI2; PTHLH; SOX9; EFEMP1; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	7	20	35	0.0195889287249634	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TBX1; NR2F2; FLT4; ID1; SLC1A1; EFNB2; LAMA1;	GO:0048514~blood vessel morphogenesis	7	20	35	0.0195889287249634	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CCL24; DEFB4A; CCL16; CREB3; PLAU; RNASE2; FOSL1; TYMP; FPR3; L1CAM; NCKAP1L; CCL18; DEFB1; CX3CL1; CCL20; CCL8; ENPP2; RARRES2; CXCL16; PLGRKT; CCL26; CXCR1; XCR1; CCR2;	GO:0006935~chemotaxis	24	122	19.672131147541	0.0195961159635405	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	HLA-DRB1; PSMA1; NLRP6; GPR17;	GO:0002862~negative regulation of inflammatory response to antigenic stimulus	4	7	57.1428571428571	0.0224723914285401	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	UGT1A1; UGT1A3; UGT1A7; UGT1A6;	GO:0052696~flavonoid glucuronidation	4	7	57.1428571428571	0.0224723914285401	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ADA; TNF; GLI2; FOXF2; PKDCC; RARRES2;	GO:0048566~embryonic digestive tract development	6	16	37.5	0.0235347103120372	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CYP2F1; CYP2C19; CYP2A7; CYP2W1; CYP2A6; CYP2C9; CYP2G1P;	GO:0006082~organic acid metabolic process	7	21	33.3333333333333	0.0237931051809954	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CYP2C9; CYP2C19; CYP4A11; CYP2G1P; CYP2A7; CYP2F1; CYP2A6;	GO:0019373~epoxygenase P450 pathway	7	21	33.3333333333333	0.0237931051809954	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	LMX1B; EDN1; HOXA11; HOXD11; LHX1; LHX2; FOXG1; EN1; SP8;	GO:0009953~dorsal/ventral pattern formation	9	32	28.125	0.0253155295395466	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FGF10; GLI2; CDH1; PAX6; MSX1; SOX2; ISL1; LHX3;	GO:0021983~pituitary gland development	8	27	29.6296296296296	0.0271617094511112	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TNFRSF11B; LTA; TNF; KRT18; KRT8; PSMA1; PSMA2; PSMA4; CD40; PSMB8; PSMB9; PSMA5; CD40LG; TNFRSF4; PSMB3; PSME1; COMMD7; PYDC1; TNFRSF12A; PSME2; PYCARD; TNFRSF18; TRAF4;	GO:0033209~tumor necrosis factor-mediated signaling pathway	23	120	19.1666666666667	0.0276355664895497	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ATP1A2; CNN1; CAV1; KCNB2; CHRM2;	GO:0006940~regulation of smooth muscle contraction	5	12	41.6666666666667	0.0276610415389953	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	KRT14; ITGB4; LAMB3; LAMC2; LAMA3;	GO:0031581~hemidesmosome assembly	5	12	41.6666666666667	0.0276610415389953	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	APOA1; APOE; APOC3; APOA4; CETP; LIPG;	GO:0043691~reverse cholesterol transport	6	17	35.2941176470588	0.0290633660887598	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ADA; CSF2; EDN1;	GO:0001821~histamine secretion	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	HLA-DRA; HLA-DRB1; HLA-DMA;	GO:0002503~peptide antigen assembly with MHC class II protein complex	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	F10; TFPI; F3;	GO:0007598~blood coagulation, extrinsic pathway	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	SOX1; DMRT3; LHX3;	GO:0021521~ventral spinal cord interneuron specification	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	XBP1; FOXC2; SMOC2;	GO:0035470~positive regulation of vascular wound healing	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	MESP1; GATA5; ROBO2;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	OSM; LIFR; OSMR;	GO:0038165~oncostatin-M-mediated signaling pathway	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FGF10; GLI2; TP63;	GO:0060513~prostatic bud formation	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FGF10; ALDH1A3; SOX9;	GO:0070384~Harderian gland development	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TNF; RGN; PARK7;	GO:1901671~positive regulation of superoxide dismutase activity	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	MCIDAS; CCNO; DEUP1;	GO:1903251~multi-ciliated epithelial cell differentiation	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	BUD31; PARK7; RWDD1;	GO:2000825~positive regulation of androgen receptor activity	3	4	75	0.029909333311789	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	WT1; SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	4	8	50	0.0309363827734344	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ELANE; SELE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.0309363827734344	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	WT1; SOX9; SRY; ZFPM2;	GO:2000020~positive regulation of male gonad development	4	8	50	0.0309363827734344	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TBX1; NRP2; ENG; ISL1; TBX2; ZFPM2; ROBO2; PARVA;	GO:0003148~outflow tract septum morphogenesis	8	28	28.5714285714286	0.031781229143734	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	COL6A5; CHL1; TGFB1I1; NRP2; DSCAM; MPDZ; CNTN5; ADA; LAMB1; HAPLN1; ITGB4; ENG; ITGB6; VCAM1; CDH3; TNC; AZGP1; LAMA1; ITGB8; EPHA3; EPHA8; L1CAM; ITGAE; COL15A1; MCAM; EFNB2; MFAP4; CDH6; CDH11; BCAR1; CLDN10; CX3CL1; SRPX; DPT; CNTN1; LSAMP; LAMC2; DSG2; MYBPC2; OPCML; COL19A1; POSTN; IGFBP7; LAMA4; FLG2; FREM2; CERCAM; AMTN; MUC16; PTPRU; CIB1; OMD; FERMT1; NTM; CD300A; EGFL7; CLCA2; PCDHB8; PCDHAC2; PCDHA11; PCDH7; PCDHA9; PCDHB10; PCDHGB4; PCDH18; PCDHA4; PCDHGC4; NINJ1; PCDHA12;	GO:0007155~cell adhesion	69	454	15.1982378854626	0.0334397834029622	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	ID4; DLX1; DLX2; TMEM98; DUSP10;	GO:0048715~negative regulation of oligodendrocyte differentiation	5	13	38.4615384615385	0.0350467613214429	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FLRT2; MMP11; CAV2; CAV1; FERMT1;	GO:0071711~basement membrane organization	5	13	38.4615384615385	0.0350467613214429	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	GATA4; ATP1A2; SUMO1; ANK2; SCN5A;	GO:0086004~regulation of cardiac muscle cell contraction	5	13	38.4615384615385	0.0350467613214429	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TBX1; BMP5; RIPPLY3; ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	6	18	33.3333333333333	0.0353802604188985	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	GREM1; GDNF; SOX9; LHX1; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	6	18	33.3333333333333	0.0353802604188985	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	UBE2L6; APOA1; APOE; MMP1; APOA4; LAMB1; MELTF; PGA3; PGA5; SAA1; IGFBP4; IGFBP6; IGFBP5; TNC; MMP13; B2M; FSTL1; SPARCL1; RCN1; IGFBP7; TMEM132A; NOTUM; VWA1; AMTN; HIST2H3A; TSPAN33; SHISA5; SCG3; CHRDL1; PAPPA2; EVA1A; PSENEN; DMBT1; SERPINA10;	GO:0044267~cellular protein metabolic process	34	200	17	0.0359174512197479	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	PCDH7; DSCAM; CDH1; DSG2; CADM3; NECTIN2; ROBO2; PCDH18; TENM3; PCDHB8; PCDHB10; PCDHGB4; PCDHA4; PCDHA12; PCDHGC4; PCDHA9; PCDHA11; PCDHAC2; VSTM2L; ROBO3; MYOT; CDH19; L1CAM; CDH11; CDH6; CDH3; HMCN1; CDH10; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	29	165	17.5757575757576	0.0360728876906029	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	PRSS38; PRSS37; TRABD2B; ADAMTS4; HP; HPR; F10; REN; MMP1; CTSD; ELANE; MMP3; MMP10; C1S; RBP3; DPEP1; PCSK2; MMP11; CASP14; MMP12; MMP13; MASP1; MMP16; CASP9; RHBDL3; UBE2N; HTRA3; TMPRSS15; NEDD8; MMEL1; CTRB2; PM20D1; PRSS57; ASRGL1; OVCH1; AMZ2; SVBP; DPP10; ADAMTSL1; ADGB; ADAMTS16; PYDC1; ADAMTS14; HTRA1; PARK7; MMP19; PAPPA2; ADAM33; TINAGL1; PRSS22; KLK14; ADAMTS9; FBXO2; ADAMTS5; CLCA2; KLK5; PGA5; CPA6; CPO; PLAT; PLAU; PGA3; CPA1; PGC; CPA2; PRSS21;	GO:0006508~proteolysis	66	436	15.1376146788991	0.0390685266631952	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CLDN1; ASS1; EDN1; SLC2A4; CRHBP; PCK1; POSTN; ZC3H12A; HAS2; CIB1; ADAMTS7; PYCARD; CCL8; CX3CL1; CCL26; CCL24; CCL14; CCL21; CCL19; CCL18; CCL16; CCL20; XCL1;	GO:0071356~cellular response to tumor necrosis factor	23	125	18.4	0.0391359084443732	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	PSMA2; PSMA1; PSMB8; PSMA4; PSMB9; PSMA5; PSMB3;	GO:0010499~proteasomal ubiquitin-independent protein catabolic process	7	24	29.1666666666667	0.0400018472078258	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FCN1; MASP1; COLEC11; COLEC10;	GO:0001867~complement activation, lectin pathway	4	9	44.4444444444444	0.0410274404076909	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	GATA4; FOXF1; TBX5; RBM24;	GO:0003197~endocardial cushion development	4	9	44.4444444444444	0.0410274404076909	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	HAAO; TDO2; IDO2; ACMSD;	GO:0006569~tryptophan catabolic process	4	9	44.4444444444444	0.0410274404076909	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	UGT1A1; UGT1A3; UGT1A7; UGT1A6;	GO:0052697~xenobiotic glucuronidation	4	9	44.4444444444444	0.0410274404076909	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CTAGE4; CTAGE1; CTAGE8; CTAGE3P; CTAGE6;	GO:0035459~vesicle cargo loading	5	14	35.7142857142857	0.0435378358174286	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TBX1; TBX2; SIX1; TFAP2B; ADAMTS9;	GO:0035909~aorta morphogenesis	5	14	35.7142857142857	0.0435378358174286	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FCGR2B; IL13RA2; FCRL3;	GO:0002638~negative regulation of immunoglobulin production	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	EYA2; HOXA11; SIX2;	GO:0007501~mesodermal cell fate specification	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FOXG1; ROBO3; ROBO2;	GO:0016199~axon midline choice point recognition	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CETP; NR1H3; LIPG;	GO:0032376~positive regulation of cholesterol transport	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CYP26A1; CYP26C1; CYP2W1;	GO:0034653~retinoic acid catabolic process	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	TNF; CD40; CD40LG;	GO:0051023~regulation of immunoglobulin secretion	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	PLAU; VIL1; TNFRSF12A;	GO:0061041~regulation of wound healing	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	NRP2; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	CAV2; CAV3; CAV1;	GO:0070836~caveola assembly	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	FOXF1; MYOCD; TFAP2B;	GO:0097070~ductus arteriosus closure	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	UNC5C; RGS4; TUBB3;	GO:1990791~dorsal root ganglion development	3	5	60	0.0441462658861873	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
down	PML; TNFSF10; BID; CAV1; RBCK1; TNFRSF12A; PYCARD;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	7	25	28	0.046687472285367	0.82952562495167	1	1	0.999999873474933	0.999999873474933	1
